CYCC - Cyclacel Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 516.32M
Enterprise Value 3-2.79M
Trailing P/E N/A
Forward P/E 1-2.09
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.88
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 60.31

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-28.78%
Return on Equity (ttm)-45.80%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-4.24M
EBITDA -8.91M
Net Income Avi to Common (ttm)-14.31M
Diluted EPS (ttm)-1.25
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.82M
Total Cash Per Share (mrq)1.65
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.68
Book Value Per Share (mrq)1.55

Cash Flow Statement

Operating Cash Flow (ttm)-7.41M
Levered Free Cash Flow (ttm)-6.16M

Trading Information

Stock Price History

Beta 1.86
52-Week Change 3-29.23%
S&P500 52-Week Change 317.39%
52 Week High 32.25
52 Week Low 31.28
50-Day Moving Average 31.51
200-Day Moving Average 31.48

Share Statistics

Avg Vol (3 month) 351.19k
Avg Vol (10 day) 338.62k
Shares Outstanding 512M
Float 9.66M
% Held by Insiders 119.39%
% Held by Institutions 15.69%
Shares Short (Aug 31, 2018) 4271.06k
Short Ratio (Aug 31, 2018) 49.31
Short % of Float (Aug 31, 2018) 42.81%
Short % of Shares Outstanding (Aug 31, 2018) 42.26%
Shares Short (prior month Jul 31, 2018) 4300.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug 1, 2016
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/12
Last Split Date 3May 31, 2016